Haafor (Singapore)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$324K Buy
1,010
+217
+27% +$66.6K 0.6% 60
2020
Q3
$213K Sell
793
-364
-31% -$97.9K 0.44% 121
2020
Q2
$304K Sell
1,157
-1,343
-54% -$358K 0.52% 75
2020
Q1
$568K Buy
+2,500
New +$681K 0.91% 19

Other funds holding ELV

Haafor (Singapore)'s ELV Position: Q4 2020 in Review

Haafor (Singapore) increased its Elevance Health (ELV) stake by 27% in Q4 2020, buying an estimated $66.6K and bringing the position to 1,010 shares worth $324K. The position accounts for 0.6% of the portfolio, ranked #60.

Haafor (Singapore) first reported a position in ELV in Q1 2020 and has held it in 4 quarters since. The position peaked at $568K in Q1 2020. 1,173 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Haafor (Singapore) held 1,010 shares of Elevance Health worth $324K as of Q4 2020.
  • Haafor (Singapore) bought 217 Elevance Health shares in Q4 2020, an estimated $66.6K.
  • Elevance Health made up 0.6% of Haafor (Singapore)'s portfolio in Q4 2020, its #60 holding.
  • Haafor (Singapore) first reported a position in Elevance Health in Q1 2020 and has held it in 4 quarters since.
  • Haafor (Singapore)'s Elevance Health position peaked at $568K in Q1 2020.
  • 1,173 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Haafor (Singapore)'s 13F filing for Q4 2020, filed 5 Feb 2021.